Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 169

The DOI matches its Crossref record.

Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?

Moussata, Driffa, Allez, Matthieu, Cazals-Hatem, Dominique, Treton, Xavier, Laharie, David, Reimund, Jean-Marie, Bertheau, Philippe, Bourreille, Arnaud, Lavergne-Slove, Anne, Brixi, Hedia, Branche, Julien, Gornet, Jean-Marc, Stefanescu, Carmen, Moreau, Jacques, Marteau, Philippe, Pelletier, Anne-Laure, Carbonnel, Franck, Seksik, Philippe, Simon, Marion, Fléjou, Jean-François, Colombel, Jean-Fréderic, Charlois, Anne-Laure, Roblin, Xavier, Nancey, Stéphane, Bouhnik, Yoram, Berger, Françoise, Flourié, Bernard · 2018 · Gut

Abstract

Background: Colonoscopy with pan-chromoendoscopy (CE) is superior to standard colonoscopy in detecting neoplasia in patients with IBD. Performing random biopsies in unsuspicious mucosa after CE remains controversial. Methods: Consecutive patients with IBD who underwent surveillance colonoscopy using CE were prospectively included. The standardised procedure used CE, performed targeted biopsies or endoscopic resection on suspicious lesions and then quadrant random biopsies every 10 cm. A panel of five expert pathologists reviewed histological slides with dysplasia. Logistic regression model was used to evidence the factors associated with neoplasia in any or in random biopsies. Results: 1000 colonoscopes were performed in 1000 patients (495 UC, 505 Crohn's colitis). In 82 patients, neoplasia was detected from targeted biopsies or removed lesions, and among them dysplasia was detected also by random biopsies in 7 patients. Importantly, in 12 additional patients dysplasia was only detected by random biopsies. Overall, 140 neoplastic sites were found in 94 patients, 112 (80%) from targeted biopsies or removed lesions and 28 (20%) by random biopsies. The yield of neoplasia by random biopsies only was 0.2% per-biopsy (68/31 865), 1.2% per-colonoscopy (12/1000) but 12.8% per-patient with neoplasia (12/94). Dysplasia detected by random biopsies was associated with a personal history of neoplasia, a tubular appearing colon and the presence of primary sclerosing cholangitis (PSC). Conclusions: Despite their low yield, random biopsies should be performed in association with CE in patients with IBD with a personal history of neoplasia, concomitant PSC or a tubular colon during colonoscopy. Trial registration number: IRB 001508, Paris 7 University.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2016-311892

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 169

Metadata

Authors
Moussata, D., Allez, M., Cazals-Hatem, D., Treton, X., Laharie, D., Reimund, J.-M., Bertheau, P., Bourreille, A., Lavergne-Slove, A., Brixi, H., Branche, J., Gornet, J.-M., Stefanescu, C., Moreau, J., Marteau, P., Pelletier, A.-L., Carbonnel, F., Seksik, P., Simon, M., Fléjou, J.-F., Colombel, J.-F., Charlois, A.-L., Roblin, X., Nancey, S., Bouhnik, Y., Berger, F., & Flourié, B.
Venue
Gut
Publisher
BMJ
Published
2017-01-23
Volume
67
Issue
4
Pages
616-624
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2581987318
Cited by
169
References
0
FWCI
9.26
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy? https://app.cochat.ai/papers/10.1136/gutjnl-2016-311892
The paper
Moussata, D., Allez, M., Cazals-Hatem, D., Treton, X., Laharie, D., Reimund, J.-M., Bertheau, P., Bourreille, A., Lavergne-Slove, A., Brixi, H., Branche, J., Gornet, J.-M., Stefanescu, C., Moreau, J., Marteau, P., Pelletier, A.-L., Carbonnel, F., Seksik, P., Simon, M., . . . Flourié, B. (2018). Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy? Gut. https://doi.org/10.1136/gutjnl-2016-311892

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.